Clinical trial Recruiting at 1 site Interventional Ages 18 and up

How different implant abutment shapes and heights affect bone loss around dental implants

Official title: Influence of Supracrestal Soft Tissue on Peri-implant Bone Changes for Different Abutment Shapes and Heights: A Four-Arm Randomized Clinical Trial

Run by University of Valencia · NCT07509281 · Data updated 2026-11-12

This study tests whether the shape and height of implant abutments (2 mm vs 3 mm; cylindrical vs concave) influence bone loss and implant health in adults receiving implant-supported teeth.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment180 (estimated)
SponsorUniversity of Valencia
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Valencia, Valencia)
StatusRecruiting
StartedJune 1, 2026
Main results expectedJuly 31, 2027
Study endsSeptember 30, 2027
Registry record updatedJune 5, 2026
Trial IDNCT07509281 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with posterior edentulism, good oral health, adequate bone for implant placement without bone grafting, and readiness to follow the study protocol.

Probably not a fit

Patients with poor oral health, insufficient bone requiring augmentation, active periodontal disease, heavy smoking, or conditions contraindicating implant surgery may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized clinical trial compares four combinations of abutment type and height placed on bone-level dental implants to see how supracrestal soft tissue interactions affect marginal bone levels, implant success, probing depth, and bleeding on probing over time. Participants are adults with posterior missing teeth who meet health criteria and have sufficient bone, undergoing implant-supported rehabilitation with an one-abutment-one-time protocol. Implants are placed about 2 mm below the crest, and four groups receive different abutment configurations to isolate shape and height effects. Outcomes include changes in marginal bone level, PPD, BoP, and overall implant success. The study aims to determine if abutment design choices influence clinical performance and bone remodeling.

Why it matters

Potential benefit: If successful, findings could guide clinicians in selecting abutment shapes and heights to minimize bone loss and improve implant longevity.

How similar studies have gone: Previous trials have explored abutment design effects on soft tissue and bone around implants, but this study adds a direct comparison of specific height and shape combinations in a randomized design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older.
* Posterior edentulism (premolars/molars).
* Good general and oral health, with controlled plaque and bleeding indices.
* Sufficient bone height and width for implant placement without the need for bone regeneration procedures. Patients who require indirect sinus lift procedure simultaneously with implant placement may be included in the study.
* Presence of at least 2 mm of keratinized mucosa around the dental implant.
* Stable occlusion and healthy periodontium.
* Insertion torque ≥ 35 Ncm at the time of implant placement.
* Willingness to comply with study protocol and attend scheduled follow-up visits.

Exclusion Criteria:

* Presence of medical conditions that contraindicate implant surgery, such as heavy smoking (\>10 cigarettes per day), severe bruxism, pregnancy or breastfeeding, bisphosphonate therapy, and patients undergoing chemotherapy or radiotherapy in the head and/or neck area.
* Active periodontal disease or peri-implant infection.
* Uncooperative patients or patients unable to complete follow- up.
* Implant failures.

Where it's running

  • Universitat de València
    Valencia, Valencia, Spain
    Recruiting

Study contacts

  • Principal investigator: María I Suárez Antoima, DDS — Universitat de València
  • Study coordinator: Juan C Bernabeu Mira, DDS, MSc, PhD
  • Email: juan.c.bernabeu@uv.es
  • Phone: +34 697348312

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.